In clinical trials, researchers are restoring vision to ​people blinded by a condition called retinitis pigmentosa by inserting a light-sensitive protein in the retina. Researchers also hope optogenetics could ⁠improve cochlea implants, allowing more precise stimulation of the au

Archive